Australia markets closed

Giant Biogene Holding Co., Ltd. (2367.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
50.250+1.700 (+3.50%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,524,143
3,524,143
2,364,445
1,552,486
1,190,479
Cost of revenue
577,006
577,006
369,205
198,149
183,409
Gross profit
2,947,137
2,947,137
1,995,240
1,354,337
1,007,069
Operating expenses
Research development
74,968
74,968
44,043
24,954
13,381
Selling general and administrative
1,261,160
1,261,160
817,443
418,485
162,308
Total operating expenses
1,282,264
1,282,264
816,615
422,669
195,659
Operating income or loss
1,664,873
1,664,873
1,178,625
931,668
811,410
Interest expense
112
112
21
0
-
Income before tax
1,745,089
1,745,089
1,177,749
972,917
973,242
Income tax expense
296,887
296,887
176,163
144,785
146,757
Income from continuing operations
1,448,202
1,448,202
1,001,586
828,132
826,485
Net income
1,451,753
1,451,753
1,002,025
828,132
826,450
Net income available to common shareholders
1,451,753
1,451,753
1,002,025
828,132
826,450
Basic EPS
1.24
1.49
0.99
0.84
0.83
Diluted EPS
1.24
1.48
0.98
0.84
0.83
Basic average shares
995,000
976,278
703,130
991,609
991,609
Diluted average shares
995,000
982,717
1,021,215
991,609
991,609